TNI BioTech, Inc., Announces an Extension to the Record Date of its wholly owned subsidiary, Cytocom Inc., and Dividend now Set for September 30, 2014 |
| August 15, 2014 | August 2014 Bond Updates |
|
ORLANDO, Fla., Aug. 14, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC-BB: TNIB) ("we" or the "Company") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, announced today that the Company is... |
| View more at: http://www.prnewswire.com/news-releases/tni-biotech-inc-announces-an-extension-to-the-record-date-of-its-wholly-owned-subsidiary-cytocom-inc-and-dividend-now-set-for-september-30-2014-271266681.html |
| Related News |
|